Snehaa Organics (SNEHAA)

Score breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Low P/E of 6.41 at a market cap of ₹47 Cr offers potential margin of safety if earnings remain stable.
• ROCE of 58.77% indicates highly efficient use of capital and possible niche pricing power.
• Latest quarter net margin is strong: ₹3 Cr profit on ₹14 Cr sales, roughly 21%.
• Promoter holding of 73.68% aligns management interests with minority shareholders.

Concerns

• Piotroski F-Score of 3/9 signals weak financial health and possible cash flow or working capital stress.
• Zero sales and profit growth means the company is not compounding earnings.
• No dividend, so investors get no cash return while growth is absent.
• Insufficient data on book value and debt limits assessment of downside protection.

AI Analysis

At ₹45, Snehaa Organics sits at a ₹47 Cr market cap with a P/E of 6.41. On the surface, that looks like a Graham special: a low price against earnings. But I have learned that a cheap price is only meaningful when I understand the business. Here, I see a specialty chemicals company that earned ₹3 Cr on ₹14 Cr of sales in the latest quarter—a strong 21% margin—and an ROCE of 58.77%, which is impressive by any standard. Yet the same numbers show zero sales and profit growth, and the Piotroski F-Score of 3 out of 9 is a serious warning about financial health. That F-Score tells me the company may be generating good returns but could be fragile in other ways—cash flows, leverage, or working capital—and I don't have the full accounts to dig deeper. There is no dividend, so my return depends entirely on future earnings and management's capital allocation. I like the 73.68% promoter holding; it aligns owners with managers, though it also means low floating stock and potentially volatile trading. At this size, with limited data on book value and debt, I cannot estimate intrinsic value with confidence. Is it a hidden gem or a value trap? The low P/E and high ROCE tempt me, but the zero growth and weak F-Score keep me cautious. I would not classify Snehaa as a stalwart; it looks more like a slow grower or possible turnaround. I will wait for evidence of improving fundamentals, and only then revisit.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer